Rare diseases
Investigational molecules
Locations
Industriparken 55, 2750 Ballerup, Denmark
Leo Pharma A/S focuses on inflammatory skin disease research centered on atopic dermatitis, including moderate-to-severe disease in adults, children, and infants. Its portfolio also includes work in atopic hand eczema, reflecting interest in difficult-to-treat eczematous conditions with substantial symptom burden and impact on daily function.
Research activity in this area includes biologic and topical approaches aimed at controlling skin inflammation, improving lesion extent and symptom severity, and addressing quality-of-life effects in younger patients and caregivers.
Leo Pharma A/S runs clinical trials in conditions such as Dermatitis atopic, Pustular psoriasis, Palmoplantar pustulosis, Pyoderma gangrenosum, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Study of Delgocitinib Cream for Adults with Mild to Severe Palmoplantar Pustulosis: A 16-Week Treatment Trial
GermanyStudy on Spesolimab for Adults with Pyoderma Gangrenosum Requiring Systemic Therapy
AustriaA Phase 3 Study of Delgocitinib Cream to Evaluate Efficacy and Safety in Adult Women with Lichen Sclerosus
FranceStudy on Tralokinumab for Children Aged 6-11 with Moderate-to-Severe Atopic Dermatitis
CzechiaStudy on Tralokinumab and Topical Corticosteroids for Children and Infants with Moderate-to-Severe Atopic Dermatitis
BelgiumStudy on Tralokinumab for Moderate-to-Severe Atopic Hand Eczema in Patients Needing Systemic Therapy
BelgiumStudy on Long-Term Spesolimab Treatment for Patients with Generalized Pustular Psoriasis from Previous Trials
BelgiumStudy on Adjustable Brodalumab Dosage for Patients with Moderate-to-Severe Plaque Psoriasis Weighing 120 kg or More
BelgiumStudy on Spesolimab for Treating Recurrent Flares in Patients with Generalized Pustular Psoriasis
BelgiumStudy on the Effects of LEO 138559 for Adults with Moderate-to-Severe Atopic Dermatitis
CzechiaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
